Medtronic plcMDTNYSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank29
3Y CAGR-0.3%
5Y CAGR+0.3%
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-0.3%/yr
vs -3.2%/yr prior
5Y CAGR
+0.3%/yr
Consistent
Acceleration
+3.0pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
202527.49%+8.4%
202425.35%-9.0%
202327.85%+0.5%
202227.70%+10.9%
202124.98%-7.5%
202027.01%-11.2%
201930.43%-3.7%
201831.60%+9.0%
201728.99%-2.1%
201629.63%-